Reactome: A Curated Pathway Database

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Zajonc, Dirk M

_displayNameZajonc, Dirk M
_timestamp2017-08-22 20:41:38
affiliation[Affiliation:8856597] La Jolla Institute for Allergy and Immunology, Division of Cell Biology
created[InstanceEdit:5676482] Garapati, Phani Vijay, 2015-02-19
firstnameDirk M
modified[InstanceEdit:8856600] Shamovsky, Veronica, 2016-02-11
(author)[LiteratureReference:5676410] Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor
[LiteratureReference:8848856] Molecular mechanism of lipopeptide presentation by CD1a
[LiteratureReference:8850096] Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells
[LiteratureReference:8850246] Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A
[LiteratureReference:8850261] Role of lipid trimming and CD1 groove size in cellular antigen presentation
[LiteratureReference:8850323] Anatomy of CD1-lipid antigen complexes
[LiteratureReference:8850366] Recognition of Microbial Glycolipids by Natural Killer T Cells
[LiteratureReference:8856352] T cell activation by lipopeptide antigens
[LiteratureReference:8856354] The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode
[LiteratureReference:8856368] Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor
List all 12 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by Zajonc, Dirk M (5676467)